# Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-rimonabant-a-cannabinoid-1-receptor-blocker-on-weight-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | F. Xavier Pi‐Sunyer,Louis J. Aronne,Hassan Heshmati,Jeanne Devin,Julio Rosenstock,for the RIO-North America Study Group |
| Citations | 1,223 |
| DOI | 10.1001/jama.295.7.761 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1991778481 |
| PMID | 16478899 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Julio Rosenstock](https://scholariq.org/researchers/julio-rosenstock/)

## Paper journal

- [JAMA](https://scholariq.org/journals/jama/)

## Paper primary topic

- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)

## Paper topics

- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)
- [Forensic Toxicology and Drug Analysis](https://scholariq.org/topics/forensic-toxicology-and-drug-analysis/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.